Effects of D-limonene and L-limonene on transdermal absorption of ligustrazine hydrochloride

Yaoxue Xuebao

Volumn 41, Issue 8, 2006, Pages 772-777

  Zhang, Chun Feng ^a,b   Yang, Zhong Lin ^a   Luo, Jia Bo ^b  

^a CHINA PHARMACEUTICAL UNIVERSITY   (China)

^b SOUTHERN MEDICAL UNIVERSITY   (China)

Author keywords

Enhancement mechanism; Ligustrazine hydrochloride; Limonene; Stratum corneum

Indexed keywords

CYCLOHEXENE DERIVATIVE; LIMONENE; PYRAZINE DERIVATIVE; TERPENE; TETRAMETHYLPYRAZINE;

ANIMAL; ARTICLE; CHEMISTRY; DRUG EFFECT; ISOLATION AND PURIFICATION; LIGUSTICUM; MEDICINAL PLANT; METABOLISM; MINIPIG; SCANNING ELECTRON MICROSCOPY; SKIN; SKIN ABSORPTION; STEREOISOMERISM; SWINE; ULTRASTRUCTURE;

ANIMALS; CYCLOHEXENES; LIGUSTICUM; MICROSCOPY, ELECTRON, SCANNING; PLANTS, MEDICINAL; PYRAZINES; SKIN; SKIN ABSORPTION; STEREOISOMERISM; SWINE; SWINE, MINIATURE; TERPENES;

EID: 33750178193     PISSN: 05134870     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Pilgram GS, Van Pelt AM, Spies F, et al. Cryo-electron diffraction as a tool to study local variations in the lipid organization of human stratum corneum [J]. J Microsc, 1998, 189:71-78.
2. Sweeny TM, Downing DT. The role of the lipids in the epidermal barrier to water diffusion [J]. J Invest Dermato, 1970, 55:135-140.
3. Moghimi HR, Williams AC, Barrry BW. A lamellar matrix model for stratum corneum intercellular lipids. II. Effect of geometry of the stratum corneum on permeation of model drugs 5-fluorouracil and oestradiol [J]. Int J Pharm, 1996, 131:117-129.
4. Boddé HE, van den Brink I, Koerten HK, et al. Visualization of in vitro percutaneous penetration of mercuric chloride transport through intercellular space versus cellular uptake through desmosomes [J]. J Control Release, 1991, 15:227-236.
5. Zhu QG, Hu JH, Zeng HW. Stereoselectivity of skin carboxylesterase metabolism [J]. Acta Pharm Sin, 2005, 40:322-326.
6. Kommuru TR, Khan MA, Reddy IK. Effect of chiral enhancers on the permeability optically active and racemic metoprolol across hairless mouse skin [J]. Chirality, 1999, 11:536-540.
7. Heard CM, Brain KR. Does solute stereochemistry influence percutaneous penetration [J]. Chirality, 1995, 7:305-309.
8. Mackay KM, Williams AC, Barry BW. Effect of melting point of chiral terpenes on human stratum corneum uptake [J]. Int J Pharm, 2001, 228:89-97.
9. Suedee R, Brain KR, Heard CM. Differential permeation of propranolol enantiomers across human skin in vitro from formulations containing an enantioselective excipient [J]. Chirality, 1999, 11:680-683.
10. Heard CM, Watkinson AC, Brain KR, et al. In vitro skin penetration of propanolol enantiomers [J]. Int J Pharm, 1993, 90:R5-R8.
11. Touitou E, Chow DD, Lawter JR. Chiral β-blockers for transdermal delivery [J]. Int J Pharm, 1994, 104:19-28.
12. Roy SD, Chatterjee DJ, Manoukian E, et al. Permeability of pure enantiomers of ketorolac through human cadaer skin [J]. J Pharm Sci, 1995, 84:987-990.
13. Kommuru TR, Khan MA, Reddy IK. Racemate and enantiomers of ketoprofen: phase diagram, thermodynamic studies, skin permeability, and use of chiral permeation enhancers [J]. J Pharm Sci, 1998, 87:833-840.
14. Zobrist RH, Schmid B, Feick A, et al. Pharmacokinetics of the R- and S-enantiomers of oxybutynin and N-desethyloxybutynin following oral and transdermal administration of the racemate in healthy volunteers [J]. Pharm Res, 2001, 18:1029-1034.
15. Okabe H, Takayama K, Ogura A, et al. Effect of limonene and related compounds on the percutaneous absorption of indomethacin [J]. Drug Design Del, 1989, 4:313-321.
16. Femenia-Font A, Balaguer-Fernandez C, Merino V, et al. Effect of chemical enhancers on the in vitro percutaneous absorption of sumatriptan succinate [J]. Eur J Pharm Biopharm, 2005, 61:50-55.
17. Kanikkannan N, Andega S, Burton S, et al. Formulation and in vitro evaluation of transdermal patches of melatonin [J]. Drug Dev Ind Pharm, 2004, 30:205-212.
18. El-Kattan AF, Asbill CS, Kim N, et al. Effect of formulation variables on the percutaneous permeation of ketoprofen from gel formulations [J]. Drug Deliv, 2000, 7:147-153.
19. Clarysa P, Alewaetersa K, Jadoulb A, et al. In vitro percutaneous penetration through hairless rat skin: influence of temperature, vehicle and penetration enhancers [J]. Eur J Pharm Biopharm, 1998, 46:279-283.
20. Tumbleson ME. Swine in Biomedical Research [M]. New York: Plenum Press, 1986:641-655.
21. El-Kattan AF, Asbill CS, Michniak BB. The effect of terpene enhancer lipophilicity on the percutaneous permeation of hydrocortisone formulated in HPMC gel systems [J]. Int J Pharm, 2000, 198:179-189.
22. Monti D, Chetoni P, Burgalassi S, et al. Effect of different terpene-containing essential oils on permeation of estradiol through hairless mouse skin [J]. Int J Pharm, 2002, 237:209-214.
23. Kaidi Z, Jagdish S. Mechanisms of percutaneous absorption of tamoxifen by terpenes: eugenol, D-limonene and menthone [J]. J Control Release, 1998, 55:253-260.
24. Walters KA, Hadgraft J. Pharmaceutical Skin Permeation Enhancement [M]. New York: Marcel Dekker, 1993: 269-291.
25. Bhatia KS, Singh J. Mechanism of transport enhancement of LHRH through porcine epidermis by terpenes and iontophoresis: permeability and lipid extraction studies [J]. Pharm Res, 1998, 15:1857-1862.
26. Takahashi K, Sakano H, Yoshida M, et al. Characterization of the influence of polyol fatty acid esters on the permeation of diclofenac through rat skin [J]. J Control Release, 2001, 73:351-358.
27. Yokomizo Y, Sagitani H. Effects of phospholipids on the in vitro percutaneous penetration of prednisolone and analysis of mechanism by using attenuated total reflectance-Fourier transform infrared spectroscopy [J]. J Pharm Sci, 1996, 85:1220-1226.
28. Vaddi HK, Ho PC, Chan YW, et al. Oxide terpenes as human skin penetration enhancers of haloperidol from ethanol and propylene glycol and their modes of action on stratum corneum [J]. Biol Pharm Bull, 2003, 26:220-228.
29. Wang MY, Yang YY, Heng PW. Role of solvent in interactions between fatty acids-based formulations and lipids in porcine stratum corneum [J]. J Control Release, 2004, 94:207 -216.
30. Bouwstra JA, Dubbelaar FER, Gooris GS, et al. The role of ceramide composition in the lipid organization of the skin barrier [J]. Biochim Biophys Acta, 1999, 1419: 127-136.
31. Vavrova K, Hrabalek A, Dolezal P. Enhancement effects of (R) and (S) enantiomers and the racemate of a model enhancer on permeation of theophylline through human skin [J]. Arch Dermatol Res, 2002, 294:383-385.
32. Cornwell PA, Barry BW, Bouwstra JA, et al. Modes of action of terpene penetration enhancers in human corneum skin; differential scanning calorimetry, small-angle X-ray: diffraction and enhancer uptake studies [J]. Int J Pharm, 1996, 127:9-26.
33. Koyama Y, Bando H, Yamashita F, et al. Comparative analysis of percutaneous absorption enhancement by D-limonene and oleic acid based on a skin diffusion model [J]. Pharm Res, 1994, 11:377-383.
34. Xu BL, Wang H, Xu WM. Enhancing effect of synthetic borneolon skin permeation of ligustrazine hydrochloride [J]. Chin Tradit Pat Med, 2001, 23:864-867.
35. Chen XM, Qian CM, Wang MJ, et al. Effect of azone on the transdermal absorption of ligustrazine hydrochloride [J]. North West Pharm J, 1999, 14: 110.